Pfizer-Ligand's menopause-symptom drug Duavee wins FDA nod

10/4/2013 | Reuters

Pfizer and Ligand Pharmaceuticals obtained the FDA's approval to market Duavee, a combination of bazedoxifene and conjugated estrogens, for treatment of moderate to severe menopause symptoms and for prevention of post-menopausal osteoporosis. Because of health risks associated with estrogens, the drug will carry a boxed warning.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX